You are here

Company Monitoring Page for Biomarin

latest headlines for company on cafepharma

How BioMarin Beat Expectations in Q3

Motley Fool

Fri, 11/6/20 - 09:55 am

Tags:

Biomarin, hemophilia A, earnings

BioMarin nabs FDA review for dwarfism drug vosoritide, forgoes AdComm as it eyes 2021 approval

Fierce Biotech

Wed, 11/4/20 - 10:57 pm

Tags:

Biomarin, FDA, vosoritide, dwarfism

BioMarin (BMRN) Files NDA for Vosoritide to Treat Dwarfism

Yahoo/Zacks.com

Fri, 08/21/20 - 11:56 am

Tags:

Biomarin, FDA, achondroplasia, dwarfism

2 major FDA rejections leave some pharma investors worried about intensification of regulations

Beckers Hospital Review

Thu, 08/20/20 - 10:51 pm

Tags:

FDA, drug approvals, drug development, Gilead Sciences, Biomarin

Is valrox dead?

EP Vantage

Thu, 08/20/20 - 11:09 am

Tags:

Biomarin, hemophilia A, valrox, gene therapy, Roche, Pfizer, FDA

FDA gets out its red pen again, rejecting BioMarin's gene therapy valrox amid durability worries

Fierce Biotech

Wed, 08/19/20 - 09:28 am

Tags:

Biomarin, FDA, valrox, hemophilia A

How Biomarin Beat Expectations in Q2

Motley Fool

Wed, 08/5/20 - 09:46 am

Tags:

Biomarin, earnings

Go or no go? Valuable drugs set for FDA decisions

EP Vantage

Wed, 07/29/20 - 10:54 am

Tags:

FDA, drug approvals, Novartis, inclisiran, Biomarin, valrox, Roche, risdiplam, GSK, belantamab mafodotin, Gilead Sciences, Galapagos, filgotinib

3 Biotech Stocks With Big Incoming Catalysts

Motley Fool

Sat, 07/25/20 - 02:25 pm

Tags:

FDA, GW Pharma, Epidiolex, filgotinib, Galapagos, Biomarin, valoctocogene roxaparvovec

With cell and gene therapy boom coming, experts at Novartis, Kite trumpet need for capacity: panel

Fierce Pharma

Wed, 06/24/20 - 11:21 pm

Tags:

cell therapy, gene therapy, Novartis, Kite Pharma, Biomarin, Astellas

BioMarin Shares Additional Promising Phase I/II Data on Hemophilia A Treatment

BioSpace

Wed, 06/17/20 - 10:00 pm

Tags:

Biomarin, clinical trials, hemophilia A, valoctocogene roxaparvovec

BioMarin gene therapy shows sustained benefit in hemophilia A study

Seeking Alpha

Mon, 06/1/20 - 10:42 am

Tags:

Biomarin, hemophilia A, clinical trials, gene therapy, valoctocogene roxaparvovec

BioMarin Extends Gene Therapy Leadership with DiNAQOR in a Preclinical Collaboration and License Agreement to Develop Gene Therapies for Rare Genetic Cardiomyopathies

Yahoo/PR Newswire

Sun, 05/3/20 - 07:53 pm

Tags:

Biomarin, DiNAQOR, gene therapy, cardiomyopathy

BioMarin Blows Past Q1 Estimates, Projects 1st Year of Profitability in 2020

Motley Fool

Thu, 04/30/20 - 10:25 am

Tags:

Biomarin, earnings

10 Drugs Expected to Enter the Market This Year Could be Blockbusters, Analysis Says

BioSpace

Mon, 03/9/20 - 11:10 pm

Tags:

biosimilars, Amgen, Allergan, Roche, Rituxan, Bristol-Myers Squibb, ozanimod, risdiplam, Biomarin, valrox

BioMarin's Novel Treatment Promises to Disrupt Competitors

Motley Fool

Wed, 02/26/20 - 10:45 am

Tags:

Biomarin, gene therapy, valrox, hemophilia A

FDA Gives BioMarin Pharmaceuticals' Hemophilia Gene Therapy Priority Review

Motley Fool

Thu, 02/20/20 - 11:41 pm

Tags:

FDA, Biomarin, priority review, valrox, gene therapy, hemophilia A

Blockbusters in waiting: drug launches to watch in 2020

Pharmaforum

Mon, 02/17/20 - 11:33 pm

Drugmaker BioMarin Seeks New CFO Amid Coming Release Of Potentially Costliest Drug In The World

Forbes

Thu, 02/6/20 - 11:37 pm

Tags:

Biomarin, valrox, gene therapy, hemophilia A

BioMarin Considers $3 Million Price Tag for New Hemophilia Gene Therapy

Motley Fool

Thu, 01/16/20 - 11:27 pm

Tags:

Biomarin, JPMHC 2020, drug pricing, valrox, hemophilia

Pages

last 30 twitter posts